1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drugs 1.2.3 Medical Devices 1.3 Market by Application 1.3.1 Global Prostate Cancer Therapeutics Market Share by Sale Channel: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Therapeutics Market Perspective (2016-2027) 2.2 Prostate Cancer Therapeutics Growth Trends by Regions 2.2.1 Prostate Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Prostate Cancer Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Prostate Cancer Therapeutics Industry Dynamic 2.3.1 Prostate Cancer Therapeutics Market Trends 2.3.2 Prostate Cancer Therapeutics Market Drivers 2.3.3 Prostate Cancer Therapeutics Market Challenges 2.3.4 Prostate Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Therapeutics Players by Revenue 3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Therapeutics Revenue 3.4 Global Prostate Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2020 3.5 Prostate Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Prostate Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Therapeutics Breakdown Data by Type 4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2022-2027) 5 Prostate Cancer Therapeutics Breakdown Data by Sale Channel 5.1 Global Prostate Cancer Therapeutics Historic Market Size by Sale Channel (2016-2021) 5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2022-2027) 6 North America 6.1 North America Prostate Cancer Therapeutics Market Size (2016-2027) 6.2 North America Prostate Cancer Therapeutics Market Size by Type 6.2.1 North America Prostate Cancer Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Prostate Cancer Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Prostate Cancer Therapeutics Market Size by Type (2016-2027) 6.3 North America Prostate Cancer Therapeutics Market Size by Sale Channel 6.3.1 North America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) 6.3.2 North America Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) 6.3.3 North America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2027) 6.4 North America Prostate Cancer Therapeutics Market Size by Country 6.4.1 North America Prostate Cancer Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Prostate Cancer Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Prostate Cancer Therapeutics Market Size (2016-2027) 7.2 Europe Prostate Cancer Therapeutics Market Size by Type 7.2.1 Europe Prostate Cancer Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Prostate Cancer Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Prostate Cancer Therapeutics Market Size by Type (2016-2027) 7.3 Europe Prostate Cancer Therapeutics Market Size by Sale Channel 7.3.1 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) 7.3.2 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) 7.3.3 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2027) 7.4 Europe Prostate Cancer Therapeutics Market Size by Country 7.4.1 Europe Prostate Cancer Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Prostate Cancer Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type 8.2.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel 8.3.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) 8.3.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) 8.3.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2027) 8.4 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region 8.4.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prostate Cancer Therapeutics Market Size (2016-2027) 9.2 Latin America Prostate Cancer Therapeutics Market Size by Type 9.2.1 Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Prostate Cancer Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel 9.3.1 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) 9.3.2 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) 9.3.3 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2027) 9.4 Latin America Prostate Cancer Therapeutics Market Size by Country 9.4.1 Latin America Prostate Cancer Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Prostate Cancer Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type 10.2.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel 10.3.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) 10.3.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) 10.3.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2027) 10.4 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country 10.4.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Prostate Cancer Therapeutics Introduction 11.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Prostate Cancer Therapeutics Introduction 11.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Amgen 11.3.1 Amgen Company Details 11.3.2 Amgen Business Overview 11.3.3 Amgen Prostate Cancer Therapeutics Introduction 11.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.3.5 Amgen Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction 11.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.4.5 Johnson & Johnson Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction 11.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Prostate Cancer Therapeutics Introduction 11.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.6.5 AbbVie Recent Development 11.7 Bayer 11.7.1 Bayer Company Details 11.7.2 Bayer Business Overview 11.7.3 Bayer Prostate Cancer Therapeutics Introduction 11.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.7.5 Bayer Recent Development 11.8 Ipsen Group 11.8.1 Ipsen Group Company Details 11.8.2 Ipsen Group Business Overview 11.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction 11.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.8.5 Ipsen Group Recent Development 11.9 Endo Pharmaceuticals 11.9.1 Endo Pharmaceuticals Company Details 11.9.2 Endo Pharmaceuticals Business Overview 11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction 11.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.9.5 Endo Pharmaceuticals Recent Development 11.10 Dendreon Corporation(Sanpower Group Co. Ltd.) 11.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details 11.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview 11.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction 11.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2016-2021) 11.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Prostate Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drugs Table 3. Key Players of Medical Devices Table 4. Global Prostate Cancer Therapeutics Market Size Growth by Sale Channel (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Prostate Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Prostate Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Prostate Cancer Therapeutics Market Share by Regions (2016-2021) Table 8. Global Prostate Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Prostate Cancer Therapeutics Market Share by Regions (2022-2027) Table 10. Prostate Cancer Therapeutics Market Trends Table 11. Prostate Cancer Therapeutics Market Drivers Table 12. Prostate Cancer Therapeutics Market Challenges Table 13. Prostate Cancer Therapeutics Market Restraints Table 14. Global Prostate Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Prostate Cancer Therapeutics Market Share by Players (2016-2021) Table 16. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics as of 2020) Table 17. Ranking of Global Top Prostate Cancer Therapeutics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prostate Cancer Therapeutics Product Solution and Service Table 21. Date of Enter into Prostate Cancer Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2016-2021) Table 25. Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Prostate Cancer Therapeutics Market Size Share by Sale Channel (2016-2021) & (US$ Million) Table 28. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2016-2021) Table 29. Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2022-2027) (US$ Million) Table 30. Global Prostate Cancer Therapeutics Revenue Market Share by Sale Channel (2022-2027) & (US$ Million) Table 31. North America Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million) Table 34. North America Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million) Table 35. North America Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million) Table 40. Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million) Table 41. Europe Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million) Table 46. Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million) Table 47. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million) Table 52. Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million) Table 53. Latin America Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million) Table 58. Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million) Table 59. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 61. Sanofi Company Details Table 62. Sanofi Business Overview Table 63. Sanofi Prostate Cancer Therapeutics Product Table 64. Sanofi Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 65. Sanofi Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Prostate Cancer Therapeutics Product Table 69. Pfizer Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 70. Pfizer Recent Development Table 71. Amgen Company Details Table 72. Amgen Business Overview Table 73. Amgen Prostate Cancer Therapeutics Product Table 74. Amgen Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 75. Amgen Recent Development Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Prostate Cancer Therapeutics Product Table 79. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 80. Johnson & Johnson Recent Development Table 81. AstraZeneca Company Details Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Prostate Cancer Therapeutics Product Table 84. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 85. AstraZeneca Recent Development Table 86. AbbVie Company Details Table 87. AbbVie Business Overview Table 88. AbbVie Prostate Cancer Therapeutics Product Table 89. AbbVie Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 90. AbbVie Recent Development Table 91. Bayer Company Details Table 92. Bayer Business Overview Table 93. Bayer Prostate Cancer Therapeutics Product Table 94. Bayer Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 95. Bayer Recent Development Table 96. Ipsen Group Company Details Table 97. Ipsen Group Business Overview Table 98. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 99. Ipsen Group Recent Development Table 100. Endo Pharmaceuticals Company Details Table 101. Endo Pharmaceuticals Business Overview Table 102. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Table 103. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 104. Endo Pharmaceuticals Recent Development Table 105. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details Table 106. Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview Table 107. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Table 108. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 109. Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Drugs Features Figure 3. Medical Devices Features Figure 4. Global Prostate Cancer Therapeutics Market Share by Sale Channel: 2020 VS 2027 Figure 5. Hospital Pharmacy Case Studies Figure 6. Retail Pharmacy Case Studies Figure 7. Online Sales Case Studies Figure 8. Prostate Cancer Therapeutics Report Years Considered Figure 9. Global Prostate Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Prostate Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Prostate Cancer Therapeutics Market Share by Regions: 2020 VS 2027 Figure 12. Global Prostate Cancer Therapeutics Market Share by Regions (2022-2027) Figure 13. Global Prostate Cancer Therapeutics Market Share by Players in 2020 Figure 14. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2020 Figure 16. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2016-2021) Figure 17. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2022-2027) Figure 18. North America Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Prostate Cancer Therapeutics Market Share by Type (2016-2027) Figure 20. North America Prostate Cancer Therapeutics Market Share by Sale Channel (2016-2027) Figure 21. North America Prostate Cancer Therapeutics Market Share by Country (2016-2027) Figure 22. United States Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Prostate Cancer Therapeutics Market Share by Type (2016-2027) Figure 26. Europe Prostate Cancer Therapeutics Market Share by Sale Channel (2016-2027) Figure 27. Europe Prostate Cancer Therapeutics Market Share by Country (2016-2027) Figure 28. Germany Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Prostate Cancer Therapeutics Market Share by Type (2016-2027) Figure 36. Asia-Pacific Prostate Cancer Therapeutics Market Share by Sale Channel (2016-2027) Figure 37. Asia-Pacific Prostate Cancer Therapeutics Market Share by Region (2016-2027) Figure 38. China Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Prostate Cancer Therapeutics Market Share by Type (2016-2027) Figure 46. Latin America Prostate Cancer Therapeutics Market Share by Sale Channel (2016-2027) Figure 47. Latin America Prostate Cancer Therapeutics Market Share by Country (2016-2027) Figure 48. Mexico Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Prostate Cancer Therapeutics Market Share by Type (2016-2027) Figure 52. Middle East & Africa Prostate Cancer Therapeutics Market Share by Sale Channel (2016-2027) Figure 53. Middle East & Africa Prostate Cancer Therapeutics Market Share by Country (2016-2027) Figure 54. Turkey Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 58. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 59. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 61. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 62. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 63. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 64. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 65. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 66. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Sanofi Pfizer Amgen Johnson & Johnson AstraZeneca AbbVie Bayer Ipsen Group Endo Pharmaceuticals Dendreon Corporation(Sanpower Group Co. Ltd.)